EQUITY NOTICE: Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action – SGYP

NEW YORK--()--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through November 14, 2017, inclusive (the “Class Period”) of the important April 10, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Synergy investors under the federal securities laws.

To join the Synergy class action, go to http://rosenlegal.com/cases-1294.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or zhalper@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, on September 5, 2017, Synergy announced it had closed on a “non-dilutive” $300 million loan from CRG Partners III L.P., which would be available to Synergy “when needed” to fund its operations through 2019. The lawsuit further claims that on November 14, 2017, Synergy revealed that the loan agreement terms, which were not previously disclosed, prevented Synergy from accessing $200 million of the loan without conducting a dilutive secondary offering or offerings of shares to raise cash, and thus, Synergy was conducting a secondary offering of its shares. As a result, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 10, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1294.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was ranked No. 1 in the Nation for Number of Securities Class Action Settlements in 2017. The firm has been ranked in the Top 3 each year since 2013. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: 212-686-1060
Toll Free: 866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
zhalper@rosenlegal.com
www.rosenlegal.com

Recent Stories

RSS feed for Rosen Law Firm

Release Summary

Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action – SGYP

Rosen Law Firm